Telomerase activity in human breast tumors

Journal of the National Cancer Institute

Volumn 88, Issue 2, 1996, Pages 116-122

  Hiyama, Eiso ^a,b   Gollahon, Lauren ^a   Kataoka, Tsuyoshi ^b   Kuroi, Katsumasa ^b   Yokoyama, Takashi ^b   Gazdar, Adi F ^c   Hiyama, Keiko ^a   Piatyszek, Mieczyslaw A ^a   Shay, Jerry W ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b HIROSHIMA UNIV SCHOOL OF MEDICINE   (Japan)

^c UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BREAST CARCINOMA; BREAST FIBROADENOMA; CANCER RISK; CANCER STAGING; CYSTOSARCOMA PHYLLOIDES; DIAGNOSTIC VALUE; ENZYME ACTIVITY; ENZYME ASSAY; FIBROCYSTIC BREAST DISEASE; HUMAN; HUMAN TISSUE; MALIGNANT TRANSFORMATION; POLYMERASE CHAIN REACTION; PROGNOSIS;

ADULT; AGED; AGED, 80 AND OVER; BASE SEQUENCE; BREAST DISEASES; BREAST NEOPLASMS; FEMALE; FIBROADENOMA; HUMANS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; NEOPLASM STAGING; PHYLLODES TUMOR; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; TELOMERASE;

EID: 0030033464     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/88.2.116     Document Type: Article

References (45)

1. Berg JW, Mutter RV. Breast cancer. Cancer 1995;75:257-69.
2. Harris JR, Lippma ME, Veronesi U. Walter W. Breast cancer (first of three parts) [see comment citations in Medline]. N Engl J Med 1992;327:319-28.
3. Lambe M, Hsieh C, Trichopoulos D, Ekbom A, Pavia M, Adami HO. Transient increase in the risk of breast cancer after giving birth [see comment citations in Medline]. N Engl J Med 1994;311:5-9.
4. Colditz GA, Hankinson SE, Hunter DJ, Willett WC, Manson JE, Stampfer MJ, et al. The use of estrogens and progestins and the risk of breast cancer in postmenopausal women [see comment citations in Medline]. N Engl J Med 1995;332:1589-93.
5. Morrow M. Identification and management of the woman at increased risk for breast cancer development. Breast Cancer Res Treat 1994;31:53-60.
6. Carter CL, Allen C, Henson DE. Relation of tumor size, lymph node status, and survival in 24 740 breast cancer cases. Cancer 1989;63:181-7.
7. Henson DE, Ries L, Freedman LS, Carriaga M. Relationship among outcome, stage, of disease, and histologic grade for 22616 cases of breast cancer. The basis for prognostic index. Cancer 1991;68:2143-49.
8. Muss HB, Thor AD, Berry DA, Kute T, Lui ET, Koerner F, et al. c-erbB-2 expression and response to adjuvant therapy in women with node-positive early breast cancer [see comment citation in Medline] [published erratum appears in N Engl J Med 1994;331:211]. N Engl J Med 1994;330:1260-66.
9. Sainsbury JR, Famdon JR, Needham GK, Malcolm AL, Harris AL. Epidermal growth factor receptor as predictor of early recurrence of and death from breast cancer. Lancet 1987;1:1389-402.
10. Wenger CR, Beardslee S, Owens MA, Pounds G, Oldaker T, Vendely P, et al. DNA ploidy, S-phase, and steroid receptors in more than 127 000 breast cancer patients. Breast Cancer Res Treat 1993;28:9-20.
11. van Agthoven T, Timmermans M, Foekeas JA, Dorssers LC, Henzen-Logmans SC. Differential expression of estrogen, progesterone, and epidermal growth factor receptors in normal, benign, and malignant human breast tissues using dual staining immunohistochemistry. Am J Pathol 1994;144:1238-46.
12. Thomson ME, Jensen RA, Obermiller PS, Page DL, Holt JT. Decreased expression of BRCAI accelerates growth and is often present during sporadic breast cancer progression. Nat Genet 1995;9:444-50.
13. Blackburn EH. Telomerases. Annu Rev Biochem 1992;61:113-29.
14. Zakian VA. Structure and function of telomeres. Annu Rev Genet 1989;23:579-604.
15. Watson JD. Origin of concatemeric T7 DNA. Nature New Biol (Lond) 1972;239:197-201.
16. Levy MZ, Allsopp RC, Futcher B, Greider CW, Harley CB. Telomere end-replication problem and cell aging. J Mol Biol 1992;225:951-60.
17. Greider CW, Blackburn EH. Identification of a specific telomere terminal transferase activity in Tetrahymena extracts. Cell 1985;43:405-13.
18. Morin GB. The human telomere terminal transferase enzyme is a ribonucleoprotein that synthesizes TTAGGG repeats. Cell 1989;59:521-29.
19. Feng J, Funk WD, Wang SS, Weinrich SL, Avilion AA, Chiu CP, et al. The RN A component of human telomerase. Science 1995;269:1236-41.
20. Lindsey J, McGill NI, Lindsey LA, Green DK, Cooke HJ. In vivo loss of telomeric repeats with age in humans. Mutat Res 1991;255:45-8.
21. Harley CB. Telomere loss: mitotic clock or genetic time bomb? Mutat Res 1991;256:271-82.
22. Harley CB, Kim NW, Prowse KR, Weinrich SL, Hirsch K, West MD, et al. Telomerase, cell immortality, and cancer. Cold Spring Harb Symp Quant Biol 1994;59:307-15.
23. Wright WE, Piatyszek MA, Rainey WE, Byrd W, Shay JW. Telomerase activity in human germline and embryonic tissues and cells. Devel Gen. In press.
24. Counter CM, Botelho FM, Wang P, Harley CB, Bacchetti S. Stabilization of short telomeres and telomerase activity accompany immortalization of Epstein-Barr virus-transformed human B lymphocytes. J Virol 1994; 68:3410-4.
25. Kim NW, Pialyszek MA, Prowse KR, Harley CB, West MD, Ho PL, et al. Specific association of human telomerase activity with immortal cells and cancer [see comment citations in Medline]. Science 1994;266:2011-15.
26. Shay JW, Wright WE, Werbin H. Toward a molecular understanding of human breast cancer: a hypothesis. Breast Cancer Res Treat 1993;25:83-94.
27. Hiyama E, Hiyama K, Yokoyama T, Matsuura Y, Piatyszek MA, Shay JW. Correlating telomerase activity levels with human neuroblastoma outcomes. Nature Med 1995;1:249-55.
28. Hiyama K, Hiyama E, Ishioka S, Yamakido M, Inai K, Gazdar AF, et al. Telomerase activity in small-cell and non-small-cell lung cancers. J Natl Cancer Inst 1995;87:895-902.
29. Chadeneau C, Hay K, Hirte HW, Gallinger S, Bacchetti S. Telomerase activity associated with acquisition of malignancy in human colorectal cancer. Cancer Res 1995;55:2533-36.
30. Tahara H, Nakanishi T, Kitamoto M, Nakashio R, Shay JW, Tahara E, et al. Telomerase activity in human liver tissues: comparison between chronic liver disease and hepatocellular carcinomas. Cancer Res 1995;55:2734-6.
31. Hiyama E, Yokoyama T, Tatsumoto N, Hiyama K, Imamura Y, Murakami Y, et al. Telomerase activity in gastric cancer. Cancer Res 1995;55:3258-62.
32. Beahrs OH, Henson DE, Hutter RV, Myers MH, editors. Breast, Manual for staging of cancer. 4th ed. American Joint Committee on Cancer. Philadelphia: Lippincott, 1992:150-4.
33. Piatyszek MA, Kim NW, Weinrich SL, Hiyama E, Wright WE, Shay JW. Detection of telomerase activity in human cells and tumors by a telomeric repeat amplification protocol (TRAP). Methods Cell Sci 1995;17:1-15.
34. Wright WE, Shay JW, Piatyszek MA. Modification of a telomeric repeat amplification protocol (TRAP) result in increased reliability, linearity and sensitivity. Nucleic Acids Res 1995;23:3794-5.
35. Hiyama E, Hiyama K, Yokoyama T, Ichikawa T, Matsuura Y. Length of telomeric repeats in neuroblastoma: correlation with prognosis and other biological characteristics. Jpn J Cancer Res 1992;83:159-64.
36. Hiyama E, Yokoyama T, Hiyama K, Yamakido M, Santo T, Kodama T, et al. Alteration of telomeric repeat length in adult and childhood solid neoplasias. Int J Oncol 1995;6:13-16.
37. Hiyama K, Ishioka S, Shirotani Y, Inai K, Hiyama E, Murakami I, et al. Alterations in telomeric repeat length in lung cancer are associated with loss of heterozygosity in p53 and Rb. Oncogene 1995;10:937-44.
38. Miller FR, Heppner GH. Interactions of mammary tumor subpopulations. In: Medina D, Kidwell W, Heppner G, Anderson E, editors. Cell and molecular biology of mammary lesions. New York: Plenum Press, 1987:141-62.
39. Odagiri E, Kanda N, Jibiki K, Demura R, Aikawa E, Demura H. Reduction of telomeric length and c-erbB-2 gene amplification in human breast cancer, fibroadenoma, and gynecomastia. Relationship to histologic grade and clinical parameters. Cancer 1994;73:2978-84.
40. Noguchi S, Motomura K, Inaji H, Imaoka S, Koyama H, Clonal analysis of fibroadenoma and phyllodes tumor of breast. Cancer Res 1993;53:4071-4.
41. Dietrich CU, Pandix N, Teixeira MR, Bardi G, Gerdes AM, Andersen JA, et al. Chromosomal abnormalities in benign hyperproliferative disorders of epithelial and stromal breast tissue. Int J Cancer 1995;60:49-53.
42. Koerner FC, O'Connell JX. Fibroadenoma: morphological observations and a theory of pathogenesis. Pathol Annu 1994;29:1-19.
43. Dupont WD, Page DL, Pari FF, Vnencak-Jones CL, Plummer WD Jr, Rados MS, et al. Long-term risk of breast cancer in women with fibroadenoma. N Engl J Med 1994;331:10-5.
44. Page DL, Anderson U. Diagnostic histopathology of the breast. New York: Churchill Livingston, 1987.
45. Masood S, Frykberg ER, McLellan GL, Scalapino MC, Mitchum DG, Bullard JB. Prospective evaluation of radiologically directed fine-needle aspiration biopsy of nonpalpable breast lesions. Cancer 1990;66:1480-7.